Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ZyVersa Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| INCON Co., Ltd. (10% Owner) has filed a Form 4 on ZyVersa Therapeutics, Inc. |
| 01/26/2023 |
4
| Guzman Pablo A. (Chief Medical Officer) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.11, valued at
$211k
|
|
| 12/20/2022 |
4
| Wolfe Peter (CFO) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $2.8815, valued at
$8.6k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Finizio Robert G (Director) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 29,781 options to buy
@ $11.58, valued at
$344.9k
Granted 19,854 options to buy
@ $16.36, valued at
$324.8k
Granted 9,927 options to buy
@ $16.36, valued at
$162.4k
|
|
| 12/14/2022 |
4
| Wolfe Peter (CFO) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 41,585 shares
@ $0
Granted 9,927 options to buy
@ $5.09, valued at
$50.5k
Granted 39,708 options to buy
@ $11.58, valued at
$459.8k
Granted 21,840 options to buy
@ $16.36, valued at
$357.3k
Granted 18,058 warrants
@ $6.9, valued at
$124.6k
Granted 11,763 warrants
@ $11.58, valued at
$136.2k
|
|
| 12/14/2022 |
4
| Park Min-Chul (Director) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 29,781 options to buy
@ $16.36, valued at
$487.2k
Granted 9,927 options to buy
@ $16.36, valued at
$162.4k
|
|
| 12/14/2022 |
4
| LaBella Nicholas A. Jr. (Chief Scientific Officer) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 18,094 shares
@ $0
Granted 19,854 options to buy
@ $5.03, valued at
$99.9k
Granted 39,709 options to buy
@ $5.03, valued at
$199.7k
Granted 59,563 options to buy
@ $5.03, valued at
$299.6k
Granted 39,708 options to buy
@ $11.58, valued at
$459.8k
Granted 29,781 options to buy
@ $16.36, valued at
$487.2k
Granted 18,094 warrants
@ $6.9, valued at
$124.8k
|
|
| 12/14/2022 |
4
| Cashmere Karen A. (Chief Commercial Officer) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 9,927 options to buy
@ $5.03, valued at
$49.9k
Granted 19,854 options to buy
@ $5.03, valued at
$99.9k
Granted 29,781 options to buy
@ $11.58, valued at
$344.9k
Granted 21,840 options to buy
@ $16.36, valued at
$357.3k
|
|
| 12/14/2022 |
4
| Glover Stephen C. (CEO) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Granted 448,909 shares
@ $0
Granted 85,442 shares
@ $0
Granted 49,636 shares
@ $0
Granted 43,847 shares
@ $0
Granted 18 convertible preferred
@ $10, valued at
$180
Granted 138,980 options to buy
@ $5.03, valued at
$699.1k
Granted 168,761 options to buy
@ $5.03, valued at
$848.9k
Granted 264,838 options to buy
@ $11.58, valued at
$3.1M
Granted 126,138 options to buy
@ $16.36, valued at
$2.1M
Granted 79,417 options to buy
@ $16.36, valued at
$1.3M
Granted 70,881 warrants
@ $6.9, valued at
$489.1k
|
|
| 12/14/2022 |
4
| O'Connor Daniel J. (10% Owner) has filed a Form 4 on ZyVersa Therapeutics, Inc.|
Txns:
| Acquired 1,377,598 shares
@ $0
Acquired 1,750 convertible preferred
@ $10, valued at
$17.5k
Acquired 1,750 warrants
@ $11.5, valued at
$20.1k
Acquired 177,204 warrants
@ $11.5, valued at
$2M
|
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Twitty Christopher (Director) has filed a Form 4 on Larkspur Health Acquisition Corp.|
Txns:
| Disposed of 953 options to buy
@ $0 |
|
| 03/10/2022 |
4
| Skalicky Gregory (Director) has filed a Form 4 on Larkspur Health Acquisition Corp.|
Txns:
| Disposed of 953 options to buy
@ $0 |
|
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|